Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB–IVM1c melanoma
暂无分享,去创建一个
G. Linette | J. Nemunaitis | L. Hutchins | S. Awasthi | P. Triozzi | J. Lutzky | B. Curti | E. Whitman | J. Chesney | T. Amatruda | G. Downey | Russell E. Brown | N. Batty | M. Tan | C. Windham